{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:25:59Z","timestamp":1788175559770,"version":"build-2803163510"},"reference-count":23,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Korea government","award":["2019R1G1A1007628"],"award-info":[{"award-number":["2019R1G1A1007628"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Serum biomarkers associated with severe non-cystic fibrosis (CF) bronchiectasis are currently lacking. We assessed the association of serum fibrinogen, adiponectin, and angiopoietin-2 levels with the severity and exacerbation of bronchiectasis. Methods: Serum levels of fibrinogen, adiponectin, and angiopoietin-2 were measured and compared in patients with stable non-CF bronchiectasis (n = 61) and healthy controls (n = 16). The correlations between the three biomarkers and the bronchiectasis severity index (BSI) or FACED scores were assessed. Univariate and multivariate linear regression analyses were performed to identify variables independently associated with BSI and FACED scores in patients with bronchiectasis. Additionally, the exacerbation-free survival was compared between groups of patients with high and low fibrinogen levels, while the predictors of exacerbation were analyzed using Cox proportional hazards regression. Results: Patients with non-CF bronchiectasis carried higher fibrinogen (3.00 \u00b1 2.31 vs. 1.52 \u00b1 0.74 \u00b5g\/mL; p = 0.016) and adiponectin (12.3 \u00b1 5.07 vs. 9.17 \u00b1 5.30 \u00b5g\/mL; p = 0.031) levels compared with healthy controls. The serum level of angiopoietin-2 was comparable between the two groups (1.49 \u00b1 0.96 vs. 1.21 \u00b1 0.79 ng\/mL, p = 0.277). Correlations of adiponectin and angiopoietin-2 with BSI and FACED scores were not significant. However, there were significant correlations between fibrinogen and both BSI (r = 0.428) and FACED scores (r = 0.484). Multivariate linear regression analysis revealed that fibrinogen level was an independent variable associated with both BSI and FACED scores. A total of 31 (50.8%) out of 61 patients experienced exacerbation during the follow-up period of 25.4 months. Exacerbation-free survival was significantly longer in patients with low fibrinogen levels than in those with high fibrinogen (log-rank test, p = 0.034). High fibrinogen levels and Pseudomonas colonization were independent risk factors for future exacerbation (HR 2.308; p = 0.03 and HR 2.555; p = 0.02, respectively). Conclusions: Serum fibrinogen, but not adiponectin or angiopoietin-2, is a potential biomarker closely associated with the severity and exacerbation of non-CF bronchiectasis.<\/jats:p>","DOI":"10.3390\/jcm11143948","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T07:51:56Z","timestamp":1657180316000},"page":"3948","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Serum Fibrinogen as a Biomarker for Disease Severity and Exacerbation in Patients with Non-Cystic Fibrosis Bronchiectasis"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1849-5086","authenticated-orcid":false,"given":"Seung Jun","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Pulmonology and Allergy, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju 52727, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0902-2671","authenticated-orcid":false,"given":"Jong Hwan","family":"Jeong","sequence":"additional","affiliation":[{"name":"Division of Pulmonology and Allergy, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju 52727, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manbong","family":"Heo","sequence":"additional","affiliation":[{"name":"Division of Pulmonology and Allergy, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju 52727, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunmi","family":"Ju","sequence":"additional","affiliation":[{"name":"Division of Pulmonology and Allergy, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju 52727, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Wan","family":"Yoo","sequence":"additional","affiliation":[{"name":"Division of Pulmonology and Allergy, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju 52727, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Yeong","family":"Jeong","sequence":"additional","affiliation":[{"name":"Division of Pulmonology and Allergy, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju 52727, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Deog","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Pulmonology and Allergy, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju 52727, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index. An international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_2","first-page":"1357","article-title":"Multidimensional approach to non-cystic fibrosis bronchiectasis: The FACED score","volume":"43","author":"Giron","year":"2014","journal-title":"Eur. Respir. J. Off. J. Eur. Soc. Clin. Respir. Physiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rmed.2017.04.009","article-title":"The heterogeneity of systemic inflammation in bronchiectasis","volume":"127","author":"Saleh","year":"2017","journal-title":"Respir. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.202002-0434LE","article-title":"Serum Desmosine Is Associated with Long-Term All-Cause and Cardiovascular Mortality in Bronchiectasis","volume":"202","author":"Huang","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.4187\/respcare.05276","article-title":"Serum Albumin and Disease Severity of Non-Cystic Fibrosis Bronchiectasis","volume":"62","author":"Lee","year":"2017","journal-title":"Respir. Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"14799731211017548","DOI":"10.1177\/14799731211017548","article-title":"Serum albumin is a predictor of respiratory hospitalization in patients with bronchiectasis","volume":"18","author":"Ju","year":"2021","journal-title":"Chronic Respir. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"106505","DOI":"10.1016\/j.rmed.2021.106505","article-title":"Serum hepatocyte growth factor as a predictor of disease severity and future exacerbations in patients with non-cystic fibrosis bronchiectasis","volume":"185","author":"Jeong","year":"2021","journal-title":"Respir. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1258\/0004563042466884","article-title":"Plasma fibrinogen","volume":"41","author":"Lowe","year":"2004","journal-title":"Ann. Clin. Biochem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/thoraxjnl-2012-201871","article-title":"Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease","volume":"68","author":"Duvoix","year":"2013","journal-title":"Thorax"},{"key":"ref_10","first-page":"293","article-title":"The role of the novel adipocyte-derived hormone adiponectin in human disease","volume":"148","author":"Iglesias","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.3390\/nu5104115","article-title":"Adiponectin: An attractive marker for metabolic disorders in Chronic Obstructive Pulmonary Disease (COPD)","volume":"5","author":"Bianco","year":"2013","journal-title":"Nutrients"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1378\/chest.06-2453","article-title":"Angiogenesis in chronic lung disease","volume":"131","author":"Voelkel","year":"2007","journal-title":"Chest"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2214\/ajr.165.2.7618537","article-title":"CT findings in bronchiectasis: Limited value in distinguishing between idiopathic and specific types","volume":"165","author":"Reiff","year":"1995","journal-title":"Am. J. Roentgenol."},{"key":"ref_14","first-page":"1700051","article-title":"Pulmonary exacerbation in adults with bronchiectasis: A consensus definition for clinical research","volume":"49","author":"Hill","year":"2017","journal-title":"Eur. Respir. J. Off. J. Eur. Soc. Clin. Respir. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.2147\/CMAR.S175780","article-title":"Prognostic value of plasma fibrinogen in hepatocellular carcinoma: A meta-analysis","volume":"10","author":"Huang","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.7150\/jca.26360","article-title":"Prognostic Value of Plasma Fibrinogen in Lung Cancer Patients: A Meta-Analysis","volume":"9","author":"Zhong","year":"2018","journal-title":"J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1164\/rccm.201509-1722PP","article-title":"Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium","volume":"193","author":"Miller","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/thoraxjnl-2018-211855","article-title":"Biomarkers and clinical outcomes in COPD: A systematic review and meta-analysis","volume":"74","author":"Fermont","year":"2019","journal-title":"Thorax"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9874068","DOI":"10.1155\/2017\/9874068","article-title":"Is There a Correlation between New Scoring Systems and Systemic Inflammation in Stable Bronchiectasis?","volume":"2017","author":"Coban","year":"2017","journal-title":"Can. Respir. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1513\/AnnalsATS.202002-094OC","article-title":"Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis","volume":"18","author":"Aliberti","year":"2021","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis","volume":"195","author":"Chalmers","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_22","first-page":"2001702","article-title":"Sputum neutrophil elastase in bronchiectasis: A Southern European cohort study","volume":"56","author":"Gramegna","year":"2020","journal-title":"Eur. Respir. J. Off. J. Eur. Soc. Clin. Respir. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/14\/3948\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:43:49Z","timestamp":1760139829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/14\/3948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":23,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["jcm11143948"],"URL":"https:\/\/doi.org\/10.3390\/jcm11143948","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]}}}